Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03501693 · ClinicalTrials.gov registry record
Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study
A clinical trial, sponsored by Fujifilm Medical Systems USA.
- Completed
- Registry status
- 300
- Enrollment target
NCT03501693: Completed study, sponsored by Fujifilm Medical Systems USA.
NCT03501693 is a clinical trial that has completed, run by Fujifilm Medical Systems USA. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03501693 has completed, sponsored by Fujifilm Medical Systems USA.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The purpose of the pivotal reader study is to assess the comparative accuracy of Fujifilm DBT plus S-View versus FFDM in the detection of breast cancer.
Interventions
- DEVICE FFDM Alone
- DEVICE DBT plus S-View
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2018-04-06 |
| Est. Completion | 2018-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03501693
The ClinicalTrials.gov registry entry for NCT03501693 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fujifilm Medical Systems USA, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FFDM Alone is the first listed.
NCT03501693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03501693 about?
NCT03501693 is a clinical study titled "Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study". The purpose of the pivotal reader study is to assess the comparative accuracy of Fujifilm DBT plus S-View versus FFDM in the detection of breast cancer.
What is the current status of trial NCT03501693?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2018-04-06. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT03501693?
The interventions under investigation include: FFDM Alone (DEVICE), DBT plus S-View (DEVICE).
Who is sponsoring clinical trial NCT03501693?
This trial is sponsored by Fujifilm Medical Systems USA, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.